| Financial Year |
March 31 2023 |
| Monetary Funds |
417,765,443.11 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
44,861,531.80 |
| Accounts Receivable |
78,194,625.99 |
| Advances to Suppliers |
8,585,601.82 |
| Other Receivables |
4,335,408.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
300,975,474.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,433,220.74 |
| Total Current Assets |
882,937,445.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,185,745,386.87 |
| Under-construction Projects |
532,457,693.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
155,157,008.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,704,313.41 |
| Deferred Income Tax Assets |
14,940,833.28 |
| Other Non-Current Assets |
24,531,014.51 |
| Sub-Total of Non-Current Assets |
1,962,032,290.72 |
| Total Assets |
2,844,969,736.54 |
| Short-Term Loans |
462,410,044.35 |
| Trading Financial liabilities |
11,000.00 |
| Notes Payable |
-- |
| Accounts Payable |
172,964,764.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,013,311.05 |
| Taxes Payable |
4,706,763.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,585,781.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,283,176.83 |
| Other Current Liabilities |
41,718,202.91 |
| Sub-Total of Current Liabilities |
746,962,604.23 |
| Long-term Loans |
431,745,237.20 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
31,846,794.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
542,793,931.20 |
| Total Liabilities |
1,289,756,535.43 |
| Paid-In Capital(Or Share Stock) |
180,654,547.00 |
| Capital Surplus |
604,755,512.47 |
| Surplus Reserve |
83,863,661.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
673,024,471.41 |
| Minority Stockholder's Interest |
13,281,483.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,541,931,717.94 |
| Owner's Equity（Stockholder's Equity） |
1,555,213,201.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,844,969,736.54 |
